Nine anthraquinones, aurantio-obtusin (1), chryso-obtusin (2), obtusin (3), chryso-obtusin-2-O-b b-D-glucoside (4), physcion (5), emodin (6), chrysophanol (7), obtusifolin (8), and obtusifolin-2-O-b b-D-glucoside (9), isolated from an EtOAc-soluble extract of the seeds of Cassia tora, were subjected to in vitro bioassays to evaluate their inhibitory activity against advanced glycation end products (AGEs) formation and rat lens aldose reductase (RLAR). Among the isolates, compounds 6 and 8 exhibited a significant inhibitory activity on AGEs formation with observed IC 50 values of 118 and 28.9 m mM, respectively, in an AGEs-bovine serum albumin (BSA) assay by specific fluorescence. Furthermore, compounds 6 and 8 inhibited AGEs-BSA formation more effectively than aminoguanidine, an AGEs inhibitor, by indirect AGEs-ELISA. N e e -Carboxymethyllysine (CML)-BSA formation was also inhibited by compounds 6 and 8. Whereas compounds 1, 4, and 6 showed a significant inhibitory activity on RLAR with IC 50 values of 13.6, 8.8, and 15.9 m mM, respectively.
The Diabetes Control and Complication Trial (DCCT) has identified hyperglycemia as the main risk-factor for the development of complications. 1) Persistent hyperglycemia induces abnormal changes such as the formation of advanced glycation end products (AGEs), 2) the increase of sorbitol through the polyol pathway, 3) the overactivation of protein kinase C isoforms due to the synthesis of diacylglycerol (DAG). 4) Direct evidence indicating the contribution of AGEs in the progression of diabetic complications in different lesions of the kidneys, the rat lens, and in atherosclerosis has been recently reported. 5, 6 ) N e -Carboxymethyllysine (CML) is one of the best characterized compounds of AGEs and can be detected in tissue and serum proteins by specific antisera. 7) Aldose reductase (AR), the key enzyme in the polyol pathway, also has been demonstrated to play important roles in the pathogenesis of diabetic complications and cataract formation. 8) Thus, the design and discovery of inhibitors of AGEs formation or AR can offer a promising therapeutic approach for the prevention of diabetic or other pathogenic complications. 9, 10) In our ongoing project directed toward the discovery of preventive agents for diabetic complications from the herbal medicines, 11) the seeds of Cassia tora was chosen for more detailed investigation, since the EtOAc-soluble fraction of a MeOH extract showed a significant in vitro inhibitory effect on AGEs. Cassia tora (Leguminosae) is widely distributed in tropical Asian countries. The seeds of C. tora are reputed in Oriental medicine as vision-improving, antiasthenic, asperient, and diuretic agents. 12) C. tora have shown to possess various biological and pharmacological activities including antihepatotoxic, 13) radical scavenging, 14) antiallergic, 15) antimutagenic, 16) antifungal, 17) and antimicrobial. 18) Previous phytochemical investigation on the seeds of C. tora have resulted in the isolation of several anthraquinone and naphthopyrone derivatives. 13, [16] [17] [18] [19] [20] In the present study, further fractionation of the EtOAc-soluble extract of the seeds of C. tora led to the purification of nine anthraquinones (1) (2) (3) (4) (5) (6) (7) (8) (9) . The structures of 1-9 were determined by spectroscopic data interpretation and they were subjected to in vitro bioassays to evaluate their inhibitory activity against AGEs and RLAR. Extraction and Isolation The ground seeds of Cassia tora (15 kg) were extracted three times with MeOH (60 l) at room temperature for 3 d. The combined solutions were then evaporated under reduced pressure at under 40°C to give a MeOH extract (1302 g). The MeOH extract was suspended in H 2 O (3 l) and successively extracted with n-hexane (3ϫ3 l), EtOAc (3ϫ3 l), and BuOH (3ϫ3 l) to give n-hexane-(177 g), EtOAc-(95 g), BuOH-(172 g), and water-soluble fraction (858 g), respectively. Based on the initial biological testing, the EtOAc-soluble fraction (70.3 g, IC 50 value of 30.8 mg/ml against AGEs formation) was chromatographed over silica gel (f 9ϫ46 cm, 70-230 mesh) as the stationary phase using a CHCl 3 -MeOH gradient (from 9 : 1→0 : 1 v/v) to yield 8 pooled fractions (fractions F01-F08). Of these, fractions F03 and F04 showed the most potent AGEs inhibitory activity (IC 50 value of Ͻ20 mg/ml). Measurement of AGEs-BSA and CML-BSA Formations by Indirect ELISA After incubating, the aliquots were immediately frozen until their analysis by indirect enzyme-linked immunosorbent assay (ELISA). AGEs-and CML-ELISA were performed according to method of Engvall. 22) Briefly, 96-well polystyrene plates were coated overnight with the reaction mixture (1.5 mg/ml) in 50 mM sodium carbonate buffer, pH 9.5-9.7. After coating, the wells were blocked for 1 h at 37°C with PBS containing 1% BSA. Rabbit anti-AGEs antibodies (6D12, ThransGenic Inc., Kobe, Japan) or anti-CML antibodies (NF-1G, ThransGenic Inc., Kobe, Japan) were diluted at a titer of 1 : 3000 in PBS, incubated for 1.5 h at 37°C, and washed. An alkaline phosphatase-conjugated antibody to rabbit IgG was then added as the secondary antibody at a titer of 1 : 3000 in PBS, incubated for 1 h at 37°C, and washed again. The wells were developed with p-nitrophenyl phosphate substrate solution (pH 10.4). The reaction was terminated by adding 1 M sulfuric acid (50 mg/well) and the absorbance at 450 nm was read on a microplate reader (Synergy HT, BIO-TEK).
MATERIALS AND METHODS

General Experimental Methods
Measurement of RLAR Activity Rat lens were removed from the eyes of 8 weeks old Sprague-Dawley rats (Dae-Han Bio Link Co., Umsung, Korea) weighing 100-150 g and homogenized in 12 volumes of a 135 mM Na, Kphosphate buffer (pH 7.0) containing 0.5 mM phenylmethylsulfonyl fluoride and 10 mM 2-mercaptoethanol. The homogenate was centrifuged at 100000ϫg for 30 min, and the supernatant fluid was used as the crude rat lens aldose reductase (RLAR). RLAR activity was assayed according to the methods described previously 23, 24) with slight modification. The incubation mixture contained 135 mM Na, K-phosphate buffer (pH 7.0), 100 mM lithium sulfate, 0.03 mM NADPH, 1 mM DL-glyceraldehyde as a substrate, and 50 ml of enzyme fraction, with or without 25 ml of sample solution, in a total volume of 1.0 ml. The reaction was initiated by the addition of NADPH at 37°C and stopped by the addition of 0.3 ml of 0.5 M HCl. Then, 1 ml of 6 M NaOH containing 10 mM imidazole was added, and the solution was heated at 60°C for 10 min to convert NADP to a fluorescent product. Fluorescence was measured using a spectrofluorometric detector (Shimadzu RF-5301PC, Japan, Ex: 360, Em: 460 nm).
Both AGEs and RLAR assays were performed in quadruplicate. The concentration of each test sample giving 50% inhibition of the activities (IC 50 ) was estimated from the leastsquares regression line of the logarithmic concentration plotted against the remaining activity.
RESULTS AND DISCUSSION
Nine anthraquinones, aurantio-obtusin (1), chryso-obtusin (2), obtusin (3), chryso-obtusin-2-O-b-D-glucoside (4), physcion (5), emodin (6), chrysophanol (7), obtusifolin (8) , and obtusifolin-2-O-b-D-glucoside (9) were isolated from an EtOAc-soluble extract of the seeds of Cassia tora. The structures of the known compounds were identified by physical and spectroscopic data (mp, 1 H-, 13 C-NMR, and MS) measurement and by comparison with published values. 25, 26) To the best of our knowledge, there are just two prior reports on the isolation of chryso-obtusin-2-O-b-D-glucoside (4) 25, 27) and we now report the 13 C-NMR data of 4 for the first time. All the isolates 1-9 were subjected to in vitro bioassays to evaluate advanced glycation end products (AGEs) formation and rat lens aldose reductase (RLAR) inhibitory activity. The potential of 1-9 to inhibit AGEs-BSA formation is summarized in Table 1 . A number of natural inhibitors of AGEs formation have been reported up to date, many of them are flavonoids with IC 50 values ranging from 90 to 200 mM. 28) In this study, emodin (6) and obtusifolin (8) exhibited much stronger inhibitory activity on AGEs-BSA formation (IC 50 values of 118 and 28.9 mM, respectively) than aminoguanidine (IC 50 value of 961 mM), a well known glycation inhibitor, while others were found to be inactive. The inhibitory effects of emodin (6) and obtusifolin (8) on AGEs-BSA formation in the assay were reconfirmed by a specific AGEs-ELISA (absorbance of 450 nm). As shown in Fig. 2A , compounds 6 and 8 showed a dose-dependent inhibitory effect, the percentage inhibition of compounds 6 and 8 being more potent than that of aminoguanidine. CML-BSA formation was also inhibited by compounds 6 and 8 as a dose-dependent manner (Fig. 2B) . AGEs adducts such as pyrraline, pentosidine and CML have been found at elevated levels in diabetics. 29) AGEs inhibitors such as pyridoxamine and aminoguanidine prevent development of complications in experimental diabetes. 30) We have previously reported that magnolol showed an in vitro inhibitory effect on the formation of AGEs and prevented the progression of diabetes and diabetic nephropathy in animal models of both type 1 and type 2 diabetes.
31) Emodin (6) was recently reported as a potent inhibitor of AGEs formation from the Rhei Rhizoma. 32) In the RLAR inhibitory assay, emodin (6), which was active in the two protein glycation assay systems, also showed a good inhibitory activity on RLAR with IC 50 values of 15.9 mM. Aurantio-obtusin (1) and chryso-obtusin-2-O-b-Dglucoside (4) showed a significant inhibitory activity on RLAR with IC 50 values of 13.6 and 8.8 mM, respectively, which are comparable to that of tetramethyleneglutaric acid (IC 50 value of 24.1 mM), a positive control. Therefore, the dietary anthraquinones 1, 4, 6, and 8 seem to be worthy of consideration as potential therapeutic agents for diabetic complications and related diseases through additional biological evaluation. 
